Amedeo Smart

Free Medical Literature Service


 

Amedeo

Dermatology

  Free Subscription

08.08.2022

10 Am J Dermatopathol
6 BMC Cancer
16 Br J Dermatol
1 Cancer Lett
4 Clin Dermatol
1 Clin Exp Dermatol
1 Int J Dermatol
1 Intern Med
2 J Cutan Pathol
19 J Dermatol
2 J Invest Dermatol
2 J Laryngol Otol
6 Plast Reconstr Surg
12 PLoS One
3 Proc Natl Acad Sci U S A



    Am J Dermatopathol

  1. ZURASKI CR, Wales C, Nguyen CV, Chan EF, et al
    Cutaneous Ganglioneuromas With Overlying Epidermal Hyperplasia: A Case Series Presentation and Proposal of Potential Etiopathogenesis.
    Am J Dermatopathol. 2022 Jul 19. pii: 00000372-990000000-00062.
    >> Share

  2. TAS F, Erturk K
    Major Histotypes in Skin Melanoma: Nodular and Acral Lentiginous Melanomas Are Poor Prognostic Factors for Relapse and Survival.
    Am J Dermatopathol. 2022 Jul 19. pii: 00000372-990000000-00063.
    >> Share

  3. SNYDER AN, Zhang D, Dressen SL, Baltimore CA, et al
    Histologic Screening of Malignant Melanoma, Spitz, Dermal and Junctional Melanocytic Nevi Using a Deep Learning Model.
    Am J Dermatopathol. 2022 Jul 19. pii: 00000372-990000000-00064.
    >> Share

  4. GAGHAN LJ, Ziemer CM, Googe PB, Miedema J, et al
    Syphilis Should Be Included in the Differential of Cutaneous Lesions that Have Many CD30 Positive Cells.
    Am J Dermatopathol. 2022 Jul 19. pii: 00000372-990000000-00069.
    >> Share

  5. BUI J, Harvey NT, Berry B, Chan J, et al
    Skin Biopsy in Pediatric Oncology/Hematopoietic Stem Cell Transplantation Patients.
    Am J Dermatopathol. 2022 Jul 29. pii: 00000372-990000000-00071.
    >> Share

  6. REQUENA C, Diago A, Traves V, Llombart B, et al
    Cutaneous Ossifying Amyloidoma.
    Am J Dermatopathol. 2022 Jul 19. pii: 00000372-990000000-00066.
    >> Share

  7. JIMENEZ A, Winsett F, Kelly B, Goodwin B, et al
    Epidermotropic Cutaneous Metastasis of Colonic Adenocarcinoma Presenting as a Sister Mary Joseph Nodule.
    Am J Dermatopathol. 2022 Jul 29. pii: 00000372-990000000-00073.
    >> Share

  8. SANTANDREA G, Longo C, Borsari S, Lai M, et al
    Pigmented Actinic Keratosis Versus In Situ Melanoma: PRAME May Be Helpful.
    Am J Dermatopathol. 2022 Jul 29. pii: 00000372-990000000-00074.
    >> Share

  9. CHAN MP, Flack AB, Grisel JJ, Harms PW, et al
    Microsecretory Adenocarcinoma of the Ear Canal: Novel Cutaneous Analog of a Salivary Gland Neoplasm.
    Am J Dermatopathol. 2022 Jul 29. pii: 00000372-990000000-00077.
    >> Share

  10. BIRMINGHAM SW, Moon DJ, Kraus CN, Lee BA, et al
    Enfortumab Vedotin-Associated Toxic Epidermal Necrolysis-like Toxic Erythema of Chemotherapy.
    Am J Dermatopathol. 2022 Jul 19. pii: 00000372-990000000-00070.
    >> Share


    BMC Cancer

  11. ROHAAN MW, Stahlie EHA, Franke V, Zijlker LP, et al
    Neoadjuvant nivolumab + T-VEC combination therapy for resectable early stage or metastatic (IIIB-IVM1a) melanoma with injectable disease: study protocol of the NIVEC trial.
    BMC Cancer. 2022;22:851.
    >> Share

  12. RO V, Jones T, Silverman T, McGuinness JE, et al
    Patient, primary care provider, and stakeholder perspectives on mammography screening frequency: lessons learned from a qualitative study.
    BMC Cancer. 2022;22:819.
    >> Share

  13. LIU N, Yang DW, Wu YX, Xue WQ, et al
    Burden, trends, and risk factors for breast cancer in China from 1990 to 2019 and its predictions until 2034: an up-to-date overview and comparison with those in Japan and South Korea.
    BMC Cancer. 2022;22:826.
    >> Share

  14. HU W, Fang L, Ni R, Zhang H, et al
    Changing trends in the disease burden of non-melanoma skin cancer globally from 1990 to 2019 and its predicted level in 25 years.
    BMC Cancer. 2022;22:836.
    >> Share

  15. CHO B, Perez M, Jeffe DB, Kreuter MW, et al
    Factors associated with initiation and continuation of endocrine therapy in women with hormone receptor-positive breast cancer.
    BMC Cancer. 2022;22:837.
    >> Share

  16. ZHANG Y, Wu H, Yu Z, Li L, et al
    Germline variants profiling of BRCA1 and BRCA2 in Chinese Hakka breast and ovarian cancer patients.
    BMC Cancer. 2022;22:842.
    >> Share


    Br J Dermatol

  17. BELL KJL, Nijsten T
    Melanoma overdiagnosis: why it matters and what can be done about it.
    Br J Dermatol. 2022 Aug 5. doi: 10.1111/bjd.21750.
    >> Share

  18. MORGAN CL, Thomas M, Stander S, Jabbar-Lopez ZK, et al
    Epidemiology of prurigo nodularis in England: a retrospective database analysis.
    Br J Dermatol. 2022;187:188-195.
    >> Share

  19. SINGH R, Mohammed A, Senthilnathan A, Feldman SR, et al
    Hidradenitis suppurativa may impact clothing patterns even in patients with mild disease and symptoms: an observational study.
    Br J Dermatol. 2022;187:250-251.
    >> Share

  20. BUECHLER CR, Sagher E, Tisack A, Jacobsen G, et al
    Demographic factors and disparate outcomes in mycosis fungoides: retrospective analysis of a racially diverse 440-patient cohort from Detroit, Michigan, USA.
    Br J Dermatol. 2022;187:246-248.
    >> Share

  21. DE VERE HUNT I, Halley M, Sum K, Yekrang K, et al
    A qualitative exploration of the experiences of itch for adults living with epidermolysis bullosa.
    Br J Dermatol. 2022;187:261-263.
    >> Share

  22. YUKSEL YT, Ibler K, Agner T, Ofenloch R, et al
    Validation of the Danish version of the Quality of Life in Hand Eczema Questionnaire (QOLHEQ).
    Br J Dermatol. 2022;187:256-258.
    >> Share

  23. RING HC, Thomsen SF
    The impact of Janus kinase 1 inhibitors on quality of life in patients with hidradenitis suppurativa.
    Br J Dermatol. 2022;187:274.
    >> Share

  24. BAE JM, Kim M, Han JH, Lee S, et al
    Preventive effect of levodopa on vitiligo development: a nationwide case-control study.
    Br J Dermatol. 2022;187:259-261.
    >> Share

  25. JIANG TT, Kruglov O, Geskin L, Akilov OE, et al
    Repetitive expanded T-cell receptor clonotypes impart the classic T helper 2 Sezary cell phenotype.
    Br J Dermatol. 2022;187:265-267.
    >> Share

  26. DI RAIMONDO C, Rubio-Gonzalez B, Palmer J, Weisenburger DD, et al
    Expression of immune checkpoint molecules programmed death protein 1, programmed death-ligand 1 and inducible T-cell co-stimulator in mycosis fungoides and Sezary syndrome: association with disease stage and clinical outcome.
    Br J Dermatol. 2022;187:234-243.
    >> Share

  27. LIU Y, Tan Y, Liu J, Song Z, et al
    Novel and founder variants of SERPINA12 in Chinese patients with autosomal recessive palmoplantar keratoderma.
    Br J Dermatol. 2022;187:267-270.
    >> Share

  28. BIRABAHARAN M, Kaelber DC, Orme CM, Paravar T, et al
    Evaluating risk of bullous pemphigoid after mRNA COVID-19 vaccination.
    Br J Dermatol. 2022;187:271-273.
    >> Share

  29. PONTES FSC, Pereira GG, da Silva Santos PS, Pontes HAR, et al
    Isotretinoin and herpes simplex virus infection.
    Br J Dermatol. 2022 May 11. doi: 10.1111/bjd.21610.
    >> Share

  30. GARG A, Zema C, Kim K, Gao W, et al
    Development and initial validation of the HS-IGA: a novel hidradenitis suppurativa-specific investigator global assessment for use in interventional trials.
    Br J Dermatol. 2022;187:203-210.
    >> Share


  31. Better understanding about the severity of disease in cutaneous T-cell lymphoma from studying immune checkpoint receptors.
    Br J Dermatol. 2022;187:e69-e76.
    >> Share

  32. FENG Y, Lu Y, Wang H
    Leucoderma secondary to wig wearing.
    Br J Dermatol. 2022;187:e64.
    >> Share


    Cancer Lett

  33. DU Z, Feng Y, Zhang H, Liu J, et al
    Melanoma-derived small extracellular vesicles remodel the systemic onco-immunity via disrupting hematopoietic stem cell proliferation and differentiation.
    Cancer Lett. 2022 Jul 31:215841. doi: 10.1016/j.canlet.2022.215841.
    >> Share


    Clin Dermatol

  34. HOENIG LJ
    Cocktails Anyone? Cutaneous Hazards from Bartender Drinks.
    Clin Dermatol. 2022 Aug 2. pii: S0738-081X(22)00093.
    >> Share

  35. LAZAR AL
    Subacute cutaneous lupus erythematosus: A facultative paraneoplastic dermatosis.
    Clin Dermatol. 2022 Jul 27. pii: S0738-081X(22)00094.
    >> Share

  36. LITAIEM N, Rouai M, Slouma M, Rammeh S, et al
    Melanotic lupus erythematosus: a review of a newly described clinical form of chronic cutaneous lupus erythematosus.
    Clin Dermatol. 2022 Jul 27. pii: S0738-081X(22)00096.
    >> Share

  37. SINGH D, Levell N, Parish LC, Hoenig LJ, et al
    British Royalty and Aristocracy: Their Skin Maladies Part I: Winston Churchill: Wartime Skin Graft Donor.
    Clin Dermatol. 2022 Jul 27. pii: S0738-081X(22)00092.
    >> Share


    Clin Exp Dermatol

  38. WONG SL, Martiniuc D, Kiuru M
    CDKN2A exon 1B deletion predisposing to melanoma and neural system tumor syndrome: a case report.
    Clin Exp Dermatol. 2022 Jul 29. doi: 10.1111/ced.15354.
    >> Share


    Int J Dermatol

  39. PAKSOY T, Ustaoglu G, Yaman D, Arioz O, et al
    The link between total antioxidant status, total oxidant status, arylesterase activity, and subgingival microbiota in psoriasis patients.
    Int J Dermatol. 2022 Jul 30. doi: 10.1111/ijd.16353.
    >> Share


    Intern Med

  40. KAWAGUCHI Y, Kuba S, Morita M, Meng X, et al
    Bilateral Inflammatory Breast Cancer That Developed Two Years after Treatment for Triple-negative Breast Cancer.
    Intern Med. 2022;61:2387-2391.
    >> Share


    J Cutan Pathol

  41. NAHM WJ, Juarez M, Wu J, Kim RH, et al
    Eosinophil-rich linear IgA bullous dermatosis induced by mRNA COVID-19 booster vaccine.
    J Cutan Pathol. 2022 Aug 3. doi: 10.1111/cup.14305.
    >> Share

  42. KUZBICKI L, Brozyna AA
    The detectability of intraepidermal melanocytes - a narrative review of immunohistochemical studies.
    J Cutan Pathol. 2022 Jul 19. doi: 10.1111/cup.14295.
    >> Share


    J Dermatol

  43. FUKADA N, Suzuki T, Aoyama K, Kinjo A, et al
    Bullous pemphigoid during the treatment of psoriasis vulgaris with risankizumab.
    J Dermatol. 2022 Jul 29. doi: 10.1111/1346-8138.16534.
    >> Share

  44. SHEN M, Xiao H, Zhu W, Lu Y, et al
    Comparing willingness-to-pay and time-trade-off as the measures of burden of psoriasis: A pooled analysis of community, hospital, and web-based samples in China.
    J Dermatol. 2022 Jul 29. doi: 10.1111/1346-8138.16522.
    >> Share

  45. FUJISHIMA C, Tahara J, Munemoto S, Hioki C, et al
    Cutaneous nontuberculous mycobacterial infections in Japan: Review of the Japanese literature.
    J Dermatol. 2022 Jul 29. doi: 10.1111/1346-8138.16531.
    >> Share

  46. MELSON GJ, Hong SG, Brem CE
    Melanocytic matricoma with atypical features: A case of malignant melanocytic matricoma?
    J Dermatol. 2022 Jul 30. doi: 10.1111/1346-8138.16536.
    >> Share

  47. OTANI A, Iio K, Hataya H
    Onycholysis associated with Kawasaki disease: A comment on "Characteristic nail lesions in Kawasaki disease: Case series and literature review".
    J Dermatol. 2022;49:e291-e292.
    >> Share

  48. HIRANO Y, Kitamura S, Seo T, Yoshimoto N, et al
    Multiple actinic keratosis on the face associated with pirfenidone-induced photosensitivity.
    J Dermatol. 2022;49:e253-e254.
    >> Share

  49. YAMASHITA A, Fukui T, Akasaka E, Nakajima K, et al
    A mild case of acute generalized exanthematous pustulosis caused by gemcitabine.
    J Dermatol. 2022;49:e261-e263.
    >> Share

  50. KAMEDA E, Togawa Y, Maru Y, Matsue H, et al
    Ungual seborrheic keratosis with longitudinal melanonychia: A case report.
    J Dermatol. 2022;49:775-778.
    >> Share

  51. MIYAZAKI A, Taki T, Takeichi T, Kono M, et al
    Darier disease successfully treated with a topical agent containing vitamin A (retinyl palmitate), vitamin E, and urea.
    J Dermatol. 2022;49:779-782.
    >> Share

  52. KIM M, Kim M, Kim JW, Kim BR, et al
    Clinical characteristics of pustulotic arthro-osteitis in Korea.
    J Dermatol. 2022;49:762-768.
    >> Share

  53. TAKAMIYAGI S, Iriki H, Asahina Y, Furuichi Y, et al
    Severe graft-versus-host disease-like enterocolitis accompanied with cytomegalovirus-reactivation in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms.
    J Dermatol. 2022 May 2. doi: 10.1111/1346-8138.16415.
    >> Share

  54. LIN YC, Tu WT, Hou PC, Huang HY, et al
    Autosomal dominant epidermolysis bullosa simplex exacerbated by hyperkeratotic scabies.
    J Dermatol. 2022;49:e283-e284.
    >> Share

  55. CHEN CL, Wu CY, Lyu YS, Chou YJ, et al
    Association between bullous pemphigoid and risk of venous thromboembolism: A nationwide population-based cohort study.
    J Dermatol. 2022;49:753-761.
    >> Share

  56. HSU TC, Yu PH, Chang YH, Guevara BEK, et al
    Novel compound heterozygous indel ZMPSTE24 mutations in a Taiwanese male infant with restrictive dermopathy.
    J Dermatol. 2022;49:e280-e282.
    >> Share

  57. SHIRAHAMA T, Hamada T, Abe T, Arakawa M, et al
    Dermoscopic furrow ink test of the palmar lesion in loricrin keratoderma.
    J Dermatol. 2022;49:783-786.
    >> Share

  58. MATSUOKA A, Fujii K, Kanekura T
    Clear cell syringoma: Disappearance of clear cells after improvement in diabetes mellitus by pituitary adenoma resection.
    J Dermatol. 2022;49:e268-e269.
    >> Share

  59. MITSUISHI T, Miyata K, Ando A, Sano K, et al
    Author reply to "Onycholysis associated with Kawasaki disease: A comment on characteristic nail lesions in Kawasaki disease: Case series and literature review".
    J Dermatol. 2022;49:e293-e294.
    >> Share

  60. MIYAZAKI A, Takeichi T, Takeuchi S, Taki T, et al
    Extremely mild dominant dystrophic epidermolysis bullosa: Genotype information from whole-exome sequencing of salivary gDNA predicts disease severity.
    J Dermatol. 2022;49:e276-e277.
    >> Share

  61. TANAKA A, Yanagi T, Seo T, Mai S, et al
    Ecthyma gangrenosum caused by Streptococcus pyogenes: Report of a case and review of the literature.
    J Dermatol. 2022;49:e266-e267.
    >> Share


    J Invest Dermatol

  62. EGGERMONT C, Wakkee M, Bruggink A, Voorham Q, et al
    Development and Validation of an Algorithm to Identify Patients with Advanced Cutaneous Squamous Cell Carcinoma from Pathology Reports.
    J Invest Dermatol. 2022 Aug 1. pii: S0022-202X(22)01686.
    >> Share

  63. TUUSA J, Kokkonen N, Mattila A, Huilaja L, et al
    Dipeptidylpeptidase-4 inhibitor-associated bullous pemphigoid is characterized by an altered expression of cytokines in the skin.
    J Invest Dermatol. 2022 Jul 31. pii: S0022-202X(22)01681.
    >> Share


    J Laryngol Otol

  64. KALIA M, Dass A, Singhal SK, Gupta N, et al
    Comparative study of cholesteatoma in paediatric and adult patients.
    J Laryngol Otol. 2022 May 13:1-9. doi: 10.1017/S0022215122001104.
    >> Share

  65. LEONG WS, Gowda S, Jackson R, Chabrillac E, et al
    Superficial versus total parotidectomy for metastatic cutaneous SCC and melanoma of the head and neck: a systematic review.
    J Laryngol Otol. 2022 Aug 1:1-22. doi: 10.1017/S0022215122001724.
    >> Share


    Plast Reconstr Surg

  66. COPELAND-HALPERIN LR, Wampler AT, Doughty H, Shank N, et al
    Magnetic Resonance Imaging Screening after Silicone Implant Breast Surgery: Patient Survey of Adherence to U.S. Food and Drug Administration Recommendations.
    Plast Reconstr Surg. 2022;150:272e-278e.
    >> Share

  67. ASAAD M, Slovacek C, Mitchell D, Liu J, et al
    Implant-Based Breast Reconstruction following Infected Device Explantation: Is a Second Attempt Worth It?
    Plast Reconstr Surg. 2022;150:247e-259e.
    >> Share

  68. DU PLESSIS MI, Cottler PS, Campbell CA
    Acellular Dermal Matrix Favorably Modulates the Healing Response after Surgery.
    Plast Reconstr Surg. 2022;150:290e-299e.
    >> Share

  69. VUONG LN, Dorsey D, Obernuefemann C, Pinkner J, et al
    Characterization of Host-Pathogen-Device Interactions in Pseudomonas aeruginosa Infection of Breast Implants.
    Plast Reconstr Surg. 2022;150:260e-271e.
    >> Share

  70. JESSICA AS, Zhao J, Mackey S, Blackburn AV, et al
    Transverse Upper Gracilis Flap Breast Reconstruction: A 5-Year Consecutive Case Series of Patient-Reported Outcomes.
    Plast Reconstr Surg. 2022;150:258-268.
    >> Share

  71. HAMMOND DC, Little AK
    The Role of Premastectomy Mastopexy and Breast Reduction in the Reconstruction of the Enlarged or Ptotic Breast.
    Plast Reconstr Surg. 2022;150:270-280.
    >> Share


    PLoS One

  72. PARK S, Park SH, Byun YJ, Choi SA, et al
    Short communication: Comments on hair disorders associated with dupilumab based on VigiBase.
    PLoS One. 2022;17:e0270906.
    >> Share

  73. FUNGA ML, Dilebo ZD, Shuramo AG, Bereku T, et al
    Assessing breast cancer awareness on reproductive age women in West Badewacho Woreda, Hadiyya Zone, South Ethiopia; Community based cross- sectional study.
    PLoS One. 2022;17:e0270248.
    >> Share

  74. GEBREZGABIHER G, Yewhalaw D, Hailu A, Mekonnen Z, et al
    Evaluation of mass treatment with ivermectin program reach and survey coverage for onchocerciasis elimination in selected endemic areas of Ethiopia.
    PLoS One. 2022;17:e0271518.
    >> Share

  75. GUO YG, Zhang Y, Liu WL
    The causal relationship between allergic diseases and heart failure: Evidence from Mendelian randomization study.
    PLoS One. 2022;17:e0271985.
    >> Share

  76. KUSSAINOVA A, Kassym L, Bekenova N, Akhmetova A, et al
    Gene polymorphisms and serum levels of BDNF and CRH in vitiligo patients.
    PLoS One. 2022;17:e0271719.
    >> Share

  77. ALVES ADR, Raposo JV, de Sousa RMP, Cardoso CAA, et al
    Beyond arboviruses: A multicenter study to evaluate differential diagnosis of rash diseases and acute febrile illness cases in Rio de Janeiro, Brazil.
    PLoS One. 2022;17:e0271758.
    >> Share

  78. LAZAR IM, Karcini A, Haueis JRS
    Mapping the cell-membrane proteome of the SKBR3/HER2+ cell line to the cancer hallmarks.
    PLoS One. 2022;17:e0272384.
    >> Share

  79. SCHOTE AB, Dietrich K, Linden AE, Dzionsko I, et al
    Real sweating in a virtual stress environment: Investigation of the stress reactivity in people with primary focal hyperhidrosis.
    PLoS One. 2022;17:e0272247.
    >> Share

  80. KHAJAH MA, Khushaish S, Luqmani YA
    Glucose deprivation reduces proliferation and motility, and enhances the anti-proliferative effects of paclitaxel and doxorubicin in breast cell lines in vitro.
    PLoS One. 2022;17:e0272449.
    >> Share

  81. AMEWU RK, Akolgo GA, Asare ME, Abdulai Z, et al
    Evaluation of the fluorescent-thin layer chromatography (f-TLC) for the diagnosis of Buruli ulcer disease in Ghana.
    PLoS One. 2022;17:e0270235.
    >> Share

  82. WANG J, Chen X, Wang L, Zhang C, et al
    Does aquatic physical therapy affect the rehabilitation of breast cancer in women? A systematic review and meta-analysis of randomized controlled trials.
    PLoS One. 2022;17:e0272337.
    >> Share

  83. ELFALAH M, Sulyman N, Alrwashdeh A, Al Hajaj S, et al
    Assessing the impact of color blindness on the ability of identifying benign and malignant skin lesions by naked-eye examination.
    PLoS One. 2022;17:e0270487.
    >> Share


    Proc Natl Acad Sci U S A

  84. DING X, Sharko AC, McDermott MSJ, Schools GP, et al
    Inhibition of CDK8/19 Mediator kinase potentiates HER2-targeting drugs and bypasses resistance to these agents in vitro and in vivo.
    Proc Natl Acad Sci U S A. 2022;119:e2201073119.
    >> Share

  85. XUE J, Lin Y, Oo D, Zhang J, et al
    Lymph-derived chemokines direct early neutrophil infiltration in the lymph nodes upon Staphylococcus aureus skin infection.
    Proc Natl Acad Sci U S A. 2022;119:e2111726119.
    >> Share

  86. ONG LT, Lee WC, Ma S, Oguz G, et al
    IFI16-dependent STING signaling is a crucial regulator of anti-HER2 immune response in HER2+ breast cancer.
    Proc Natl Acad Sci U S A. 2022;119:e2201376119.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016